US EditionPublished • loading... • Updated
Renal Biomarker Market Poised for Growth Valued at USD 1.54 Billion in 2024 – FMIBlog
Summary by FMIBlog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Renal Biomarker Market Poised for Growth Valued at USD 1.54 Billion in 2024 – FMIBlog
The renal biomarker market has become an essential part of the healthcare sector, particularly in the diagnosis and management of kidney-related diseases. Renal biomarkers are biological molecules found in blood or urine that indicate the presence, progression, or severity of kidney dysfunction. The rising prevalence of chronic kidney disease (CKD), acute kidney injury (AKI), and other renal disorders has significantly increased the demand for t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
